Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

ACTIVESITE PHARMACEUTICALS, INC.

Address: 187 MAGELLAN AVENUE SAN FRANCISCO, CA 94116
County: ALAMEDA
Country: UNITED STATES
UEI: KZS5M7BSFSW3

Group Recipients By:

Issue Date FY Summary

Issue Date FY by OPDIV


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Award Number	Award Title	Award Code	Budget Year	OPDIV	Action Date	Action Amount

Issue Date FY: 2015 ( Subtotal = $0 )
2015	2013	ACTIVESITE PHARMACEUTICALS INC	1456 FOURTH STREET	BERKELEY	CA	94710	ALAMEDA	USA	R44EY019629	Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy	000	5	NIH	3/11/2015	$0
															Subtotal = $0

Issue Date FY: 2013 ( Subtotal = $699,825 )
2013	2013	ACTIVESITE PHARMACEUTICALS INC	626 BANCROFT WAY	BERKELEY	CA	94710-2224	ALAMEDA	USA	R44EY019629	Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy	000	5	NIH	2/13/2013	$699,825
															Subtotal = $699,825

Issue Date FY: 2012 ( Subtotal = $660,118 )
2012	2012	ACTIVESITE PHARMACEUTICALS INC	626 BANCROFT WAY	BERKELEY	CA	94710-2224	ALAMEDA	USA	R44EY019629	Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy	000	4	NIH	2/13/2012	$660,118
															Subtotal = $660,118

Issue Date FY: 2010 ( Subtotal = $389,453 )
2010	2010	ACTIVESITE PHARMACEUTICALS INC	626 BANCROFT WAY	BERKELEY	CA	94710-2224	ALAMEDA	USA	R44EY019629	Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy	000	3	NIH	6/14/2010	$389,453
															Subtotal = $389,453

Issue Date FY: 2009 ( Subtotal = $435,382 )
2009	2009	ACTIVESITE PHARMACEUTICALS INC	626 BANCROFT WAY	BERKELEY	CA	94710-2224	ALAMEDA	USA	R44EY019629	Novel Orally-Active Plasma Kallikrein Inhibitors for Diabetic Retinopathy	000	2	NIH	6/11/2009	$435,382
															Subtotal = $435,382

Issue Date FY: 2007 ( Subtotal = $224,868 )
2007	2007	ACTIVESITE PHARMACEUTICALS INC	626 BANCROFT WAY	BERKELEY	CA	94710	ALAMEDA	USA	R43HL090132	NOVEL ANTI-THROMBOTIC APPROACH FOR TREATMENT OF MYOCARDIAL INFARCTION	000	1	NIH	9/8/2007	$224,868
															Subtotal = $224,868

Grand Total All Awards = $2,409,646

Top

All Categories

About

Search

Reports

Data Submission

Recipient Information

ACTIVESITE PHARMACEUTICALS, INC.

Address: 187 MAGELLAN AVENUE SAN FRANCISCO, CA 94116

County: ALAMEDA

Country: UNITED STATES

UEI: KZS5M7BSFSW3

Issue Date FY Summary

Issue Date FY by OPDIV

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer